http://www.zibb.com/all/theme/cq/Inovio+Biomedical+Corporation Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Fri, 20 Nov 2009 13:04:03 GMTFri, 20 Nov 2009 13:04:03 GMT608831http://www.zibb.com/all/theme/cq/Inovio+Biomedical+Corporation http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5684572/xtremepicks+com+www+Xtremepicks+Com+Xtremepicks+Alerts+November+INO+HOL+FSP+and+CXZXtremepicks.com Alerts include Inovio Biomedical Corporation (NYSE Amex: INO), China Holdings Acquisition Corp. (AMEX: HOL), Franklin Street Properties Corp. (NYSE Amex: FSP) and Crosshair Exploration & Mining Corp. (TSX:CXX)(NYSE Amex: CXZ) Inovio Biomedical Corporation (NYSE Amex:INO) tradinghttp://www.zibb.com/article/5684572/xtremepicks+com+www+Xtremepicks+Com+Xtremepicks+Alerts+November+INO+HOL+FSP+and+CXZInovio Biomedical CorporationFri, 20 Nov 2009 13:04:03 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9137Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that its board of directors elected David J. Williams, former chairman and CEO of Sanofi Pasteur, the vaccine business of Sanofi-Aventhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9137Inovio Biomedical CorporationMon, 26 Oct 2009 01:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=151887&full=1SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE AMEX: INO) (Inovio), a leader in DNA vaccine design, development and delivery, announced today the closing of the sale, directly to institutional investors, of 11,111,110 shares of its common stock and warrants to purchase up tohttp://www.biospace.com/news_story.aspx?StoryID=151887&full=1Inovio Biomedical CorporationFri, 31 Jul 2009 12:00:00 GMThttp://www.pharmaceutical-business-review.com/article_news.asp?guid=2D72AFE0-F827-4343-8B16-451581A90972Inovio Biomedical has expanded its research license with the International AIDS Vaccine Initiative, an organization dedicated to ensuring the development of safe and effective preventive HIV vaccines.http://www.pharmaceutical-business-review.com/article_news.asp?guid=2D72AFE0-F827-4343-8B16-451581A90972Inovio Biomedical CorporationMon, 18 Aug 2008 15:12:00 GMThttp://www.prweb.com/releases/inovio/vaccine/prweb1082344.htmPR: Inovio Biomedical Corporation (AMEX:INO), a developer of electroporation-based DNA vaccine delivery technology, and VGX Pharmaceuticals, Inc., a privately held DNA vaccine developer, announced today the signing of a definitive merger agreement, which provides for the issuance of Inoviohttp://www.prweb.com/releases/inovio/vaccine/prweb1082344.htmInovio Biomedical CorporationTue, 08 Jul 2008 00:29:46 GMThttp://www.genengnews.com/news/bnitem.aspx?name=38484375Inovio Biomedical has decided to merge with VGX Pharmaceuticals in an all-stock agreement. The transaction will combine Inovio Biomedical’s electroporation-based DNA vaccine delivehttp://www.genengnews.com/news/bnitem.aspx?name=38484375Inovio Biomedical CorporationTue, 08 Jul 2008 00:00:00 GMThttp://www.dddmag.com/news-Inovio-Biomedical-and-VGX-Pharmaceuticals.aspxInovio Biomedical Corporation, a developer of electroporation-based DNA vaccine delivery technology, and VGX Pharmaceuticals, Inc., a privately held DNA vaccine developer, announced the signing of a definitive merger agreement, which provides for the issuance of Inovio Biomedical securities inhttp://www.dddmag.com/news-Inovio-Biomedical-and-VGX-Pharmaceuticals.aspxInovio Biomedical Corporationhttp://topics.nytimes.com/top/news/business/companies/inovio-biomedical-corporation/index.htmlGet Home Delivery Log In Register Now Home Page My Times Today's Paper Video Most Popular Times Topics Business All NYT New York Times Business World U.S. N.Y. / Region Business Media & Advertising World Business Small Business Your Money DealBook Markets Research Mutual Funds My Portfolio Alertshttp://topics.nytimes.com/top/news/business/companies/inovio-biomedical-corporation/index.htmlInovio Biomedical Corporationhttp://www.smartbrief.com/news/companyData.jsp?companyId=44CNS Magazine | 11 days 14 hours 23 minutes ago Wondering what to make of Pfizer's $68 billion takeout of smaller rival Wyeth? Listen to what William Steere, Pfizer's chief executive, had to say a decade ago: "Mergers in this industry are done out of weakness. We're not weak.http://www.smartbrief.com/news/companyData.jsp?companyId=44Inovio Biomedical Corporationhttp://www.pharmalive.com/News/index.cfm?articleid=593187&categoryid=63Inovio, in conjunction with its partners, is conducting pioneering studies that are advancing electroporation, a powerful delivery method designed to enhance the potency of DNA-based vaccines against infectious diseases and cancers.http://www.pharmalive.com/News/index.cfm?articleid=593187&categoryid=63Inovio Biomedical Corporationhttp://pharmabioingredients.com/news/2006/11/07/wyeth_licenses_dna_delivery_system_for_vaccinesUnder the terms of the agreement, Inovio will receive from Wyeth a $4.5 million upfront license fee, annual license maintenance fees, research support, and up to $60 million in payments based on successful completion of clinical and regulatory milestones.http://pharmabioingredients.com/news/2006/11/07/wyeth_licenses_dna_delivery_system_for_vaccinesInovio Biomedical Corporationhttp://www.datamonitor.com/print/?pid=E0366EB0-B9FB-4A08-977C-39725308FC7A&type=NewsWire&file=1Inovio Biomedical and VGX Pharmaceuticals have signed a definitive merger agreement, which provides for the issuance of Inovio Biomedical securities in exchange for all of the outstanding securities of VGX Pharmaceuticals.http://www.datamonitor.com/print/?pid=E0366EB0-B9FB-4A08-977C-39725308FC7A&type=NewsWire&file=1Inovio Biomedical Corporationhttp://www.newsrx.com/newsletters/Vaccine-Weekly/2006-12-06/421206200611VW.htmlWithin or into muscle.',250)" onMouseout="hideddrivetip()">intramuscular applications of certain therapeutic Having to do with treating disease and helping healing take place.',250)" onMouseout="hideddrivetip()">therapeutic DNA vaccines.http://www.newsrx.com/newsletters/Vaccine-Weekly/2006-12-06/421206200611VW.htmlInovio Biomedical Corporationhttp://www.bloomberg.com/apps/news?pid=conews&tkr=INO:USBloomberg Anywhere Software Support Feedback Bloomberg Bloomberg Anywhere Updated: New York, Jul 12 17:49 London, Jul 12 22:49 Tokyo, Jul 13 06:49 Search Symbol Lookup Home News Market Data Investment Tools TV and Radio About Bloomberg Careers Contact Us Tools Portfolio Tracker Market Monitor Fundhttp://www.bloomberg.com/apps/news?pid=conews&tkr=INO:USInovio Biomedical Corporationhttp://www.zibb.com/article/5676680/Inovio+Biomedical+Corp+INO+Corporate+Event+Announcement+NoticeInovio Biomedical Corp. (INO) Expected next earnings release: Announcement date: 3/31/2010 - Before Market Earnings Quarter: Q4 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5676680/Inovio+Biomedical+Corp+INO+Corporate+Event+Announcement+NoticeInovio Biomedical CorporationTue, 17 Nov 2009 21:03:40 GMThttp://www.zibb.com/article/5670505/Therapeutic+DNA+Vaccine+Company+Inovio+Biomedical+Reports+Third+Quarter+Financial+ResultsInovio Biomedical Corporation (NYSE AMEX: INO) ("Inovio") today reported financial results for the three and nine months ended September 30, 2009. Total revenue was $3.6 million and $6.5 million for the three and nine months ended September 30, 2009, respectively, compared to $455,000 andhttp://www.zibb.com/article/5670505/Therapeutic+DNA+Vaccine+Company+Inovio+Biomedical+Reports+Third+Quarter+Financial+ResultsInovio Biomedical CorporationMon, 16 Nov 2009 06:00:04 GMThttp://www.zibb.com/article/5663529/Inovio+Biomedical+to+Present+at+Global+Vaccine+ConferencesInovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that the company will highlight its technology at two worldwide vaccine conferences next week. Dr. David Weiner, Chair of Inovio's Scientific Advisory Board, and Niranjanhttp://www.zibb.com/article/5663529/Inovio+Biomedical+to+Present+at+Global+Vaccine+ConferencesInovio Biomedical CorporationThu, 12 Nov 2009 06:00:09 GMThttp://www.zibb.com/article/5659669/Inovio+Biomedical+Corp+INO+Corporate+Event+Announcement+NoticeInovio Biomedical Corp. (INO) Expected next earnings release: Announcement date: 11/18/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5659669/Inovio+Biomedical+Corp+INO+Corporate+Event+Announcement+NoticeInovio Biomedical CorporationTue, 10 Nov 2009 21:18:46 GMThttp://www.zibb.com/article/5622598/Inovio+Biomedical+Corp+INO+Corporate+Event+Announcement+NoticeInovio Biomedical Corp. (INO) Expected next earnings release: Announcement date: 11/17/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5622598/Inovio+Biomedical+Corp+INO+Corporate+Event+Announcement+NoticeInovio Biomedical CorporationTue, 27 Oct 2009 21:22:00 GMThttp://www.zibb.com/article/5605406/Inovio+Biomedical+to+Present+at+Investor+ConferencesInovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that the company will present corporate updates at two investor conferences next week. Dr. J. Joseph Kim, president and CEO, was also invited to participate on a panel,http://www.zibb.com/article/5605406/Inovio+Biomedical+to+Present+at+Investor+ConferencesInovio Biomedical CorporationWed, 21 Oct 2009 06:00:00 GMThttp://www.zibb.com/article/5601722/Inovio+Biomedical+and+Its+Collaborators+Present+Research+and+Clinical+Data+at+AIDS+Vaccine+ConferenceInovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced that Dr. David B. Weiner, Chairman of Inovio's Scientific Advisory Board, highlighted advances in electroporation-delivered SynCon(TM) DNA vaccines compared to other leading vaccinehttp://www.zibb.com/article/5601722/Inovio+Biomedical+and+Its+Collaborators+Present+Research+and+Clinical+Data+at+AIDS+Vaccine+ConferenceInovio Biomedical CorporationTue, 20 Oct 2009 06:00:02 GMThttp://www.zibb.com/article/5596426/Inovio+Biomedical+and+HVTN+initiate+Phase+I+HIV+trialInovio Biomedical, a developer of DNA vaccines, and the HIV Vaccine Trials Network or HVTN, have initiated a Phase I clinical study of Inovio's Pennvax-B preventive DNA vaccine delivered using its proprietary electroporation technology. The multi-center study will be conducted at several HVTNhttp://www.zibb.com/article/5596426/Inovio+Biomedical+and+HVTN+initiate+Phase+I+HIV+trialInovio Biomedical CorporationFri, 16 Oct 2009 13:16:35 GMThttp://www.zibb.com/article/5560940/Inovio+Biomedical+to+Present+at+Vaccine+Global+CongressInovio Biomedical Corp., a company engaged in DNA vaccine design, development and delivery, announced it will make multiple presentations at the Vaccine 3rd Global Congress being held in Singapore October 4th - 6th. In a release, the Company noted event details: Inovio representatives will behttp://www.zibb.com/article/5560940/Inovio+Biomedical+to+Present+at+Vaccine+Global+CongressInovio Biomedical CorporationWed, 30 Sep 2009 23:11:50 GMThttp://www.zibb.com/article/5552223/Inovio+Biomedical+to+Present+at+Vaccine+rd+Global+CongressInovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today it will make multiple presentations at the Vaccine 3rd Global Congress being held in Singapore October 4th -- 6th. Inovio representatives will be making the followinghttp://www.zibb.com/article/5552223/Inovio+Biomedical+to+Present+at+Vaccine+rd+Global+CongressInovio Biomedical CorporationMon, 28 Sep 2009 04:00:01 GMThttp://www.zibb.com/article/5547007/Inovio+Biomedical+CEO+Addresses+MIT+s+Emerging+Technologies+ConferenceInovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, Inovio's CEO, presented keynote remarks at MIT's Emerging Technologies Conference hosted by the Massachusetts Institute of Technology. (Read Dr. Kim'shttp://www.zibb.com/article/5547007/Inovio+Biomedical+CEO+Addresses+MIT+s+Emerging+Technologies+ConferenceInovio Biomedical CorporationThu, 24 Sep 2009 09:00:04 GMT